Graduate School of Pharmaceutical Sciences , Tohoku University , 6-3 Aza-aoba , Aramaki, Aoba-ku, Sendai 980-8578 , Japan.
J Org Chem. 2019 Jun 7;84(11):6765-6779. doi: 10.1021/acs.joc.9b00526. Epub 2019 May 22.
The structural revision of cyclotetrapeptide asperterrestide A has been achieved based on total synthesis and molecular modeling. For these studies, (2 R,3 S)-MePhe(3-OH) and (2 S,3 S)-MePhe(3-OH) suitably protected for peptide synthesis were prepared via a stereoselective reduction of a ketone precursor derived from L- or d-serine, using L-selectride or DIBAL-H. The synthesis of the proposed structure of asperterrestide A (1a) was accomplished by solution-phase synthesis of a linear precursor followed by macrolactamization. The NMR spectra of our synthetic 1a were not identical to those reported for the natural compound. Molecular modeling studies suggested that the correct structure 1b was the one in which the stereochemistry at the α-positions of the Ala and MePhe(3-OH) residues is the opposite to that of the proposed structure. This was confirmed by the total synthesis of 1b and its subsequent structural characterization.
基于全合成和分子建模,对环四肽asperterrestide A 进行了结构修订。为此研究,(2R,3S)-MePhe(3-OH)和(2S,3S)-MePhe(3-OH)通过使用 L-Selectride 或 DIBAL-H 对衍生自 L-或 D-丝氨酸的酮前体进行立体选择性还原,适当地进行了肽合成保护。通过线性前体的溶液相合成,然后进行大环内酯化,完成了asperterrestide A(1a)的提议结构的合成。我们合成的 1a 的 NMR 谱与天然化合物报道的谱不相同。分子建模研究表明,正确的结构 1b 是其中 Ala 和 MePhe(3-OH)残基的α-位置的立体化学与提议结构相反。通过 1b 的全合成及其随后的结构表征证实了这一点。